Literature DB >> 21277439

Dengue vaccine prospects: a step forward.

Bruno Guy, Jeffrey Almond, Jean Lang.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21277439     DOI： 10.1016/S0140-6736(11)60128-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.

Authors:  Xiao-Feng Li; Yong-Qiang Deng; Hui-Qiang Yang; Hui Zhao; Tao Jiang; Xue-Dong Yu; Shi-Hua Li; Qing Ye; Shun-Ya Zhu; Hong-Jiang Wang; Yu Zhang; Jie Ma; Yong-Xin Yu; Zhong-Yu Liu; Yu-Hua Li; E-De Qin; Pei-Yong Shi; Cheng-Feng Qin
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

2.  Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates.

Authors:  Luis Mier-y-Teran-Romero; Ira B Schwartz; Derek A T Cummings
Journal:  J Theor Biol       Date:  2013-05-07       Impact factor: 2.691

3.  Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.

Authors:  William B Messer; Boyd Yount; Kari E Hacker; Eric F Donaldson; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

4.  A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.

Authors:  Annie Hoi Yi Chan; Hwee Cheng Tan; Angelia Yee Chow; Angeline Pei Chiew Lim; Shee Mei Lok; Nicole J Moreland; Subhash G Vasudevan; Paul A MacAry; Eng Eong Ooi; Brendon J Hanson
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

5.  Assessing the potential of a candidate dengue vaccine with mathematical modeling.

Authors:  Mark Beatty; Maciej F Boni; Shawn Brown; Rome Buathong; Donald Burke; Laurent Coudeville; Derek A T Cummings; Robert Edelman; Jeremy Farrar; Dana A Focks; M Gabriela M Gomes; Adrienne Guignard; Scott Halstead; Joachim Hombach; Gerhart Knerer; Katia Koelle; Fook Chang Lam; Jean Lang; Ira Longini; Jan Medlock; Pem Namgyal; Mair Powell; Mario Recker; Pejman Rohani; Baudoin Standaert; Claudio Struchiner; Remy Teyssou; Helen Wearing
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

6.  Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM.

Authors:  Yayan Luo; Xiaolan Guo; Huijun Yan; Danyun Fang; Gucheng Zeng; Junmei Zhou; Lifang Jiang
Journal:  Appl Microbiol Biotechnol       Date:  2015-03-31       Impact factor: 4.813

7.  Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination.

Authors:  Laurent Coudeville; Geoff P Garnett
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

8.  Spatiotemporal dynamics of dengue epidemics, southern Vietnam.

Authors:  Hoang Quoc Cuong; Nguyen Thanh Vu; Bernard Cazelles; Maciej F Boni; Khoa T D Thai; Maia A Rabaa; Luong Chan Quang; Cameron P Simmons; Tran Ngoc Huu; Katherine L Anders
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

9.  Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody.

Authors:  Ya-Yan Luo; Jun-Jie Feng; Jun-Mei Zhou; Zhi-Zhun Yu; Dan-Yun Fang; Hui-Jun Yan; Gu-Cheng Zeng; Li-Fang Jiang
Journal:  BMC Microbiol       Date:  2013-08-29       Impact factor: 3.605

Review 10.  Introducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendations.

Authors:  Miguel Betancourt-Cravioto; Pablo Kuri-Morales; Jesús Felipe González-Roldán; Roberto Tapia-Conyer
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.